HAMED KAMAL 4
4 · Spero Therapeutics, Inc. · Filed Sep 14, 2022
Insider Transaction Report
Form 4
HAMED KAMAL
Chief Medical Officer
Transactions
- Award
Common Stock
2022-09-12+210,000→ 210,000 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on September 12, 2023, subject to the Reporting Person's continued service through the applicable vesting date.